ING-1 (Aduro)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameING-1 (Aduro)
Drug Alias NameING-1 (Triton)Targeted Nano-Therapeutics System (Triton Biosystems)anti-Ep-CAM antibody (Triton/Aduro)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEpithelial cell adhesion molecule modulators
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTriton Biosystems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTriton Biosystems IncChinook Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A